Work

POSTER: MM-1043 Efficacy of Elranatamab (ELRA) in Combination With Carfilzomib (CFZ) and Dexamethasone (DEX) in the Phase 1b MagnetisMM-20 Trial in Relapsed or Refractory Multiple Myeloma (RRMM)

Year: 2025

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(25)01317-5

Authors: Michael Tomasson, Eli Gabayan, Syed Abbas Ali, Gabriel Afram, Sona Ghorashi, Trish Creel, Luisa Paccagnella, Carolyn Lou, Ola Landgren

Institutions: University of Iowa, Beverly Hills Cancer Center, Sidney Kimmel Comprehensive Cancer Center, Pfizer (Sweden), Pfizer (United States), Sylvester Comprehensive Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4413774615

FWCI: 0.739

Cites:

Cited by: 1

Related to: 10